Literature DB >> 6650802

[Haemaccel 35: adverse reactions in a multicentric, prospective study].

K H Weis.   

Abstract

Polygeline (haemaccel 35 Behringwerke) was tested in 1147 patients in a prospective and multicentre study facing systemic anaphylactoid or cutaneous anaphylactoid side effects. 8 patients showed mainly cutaneous reactions (redness and itchy swelling) and only one an increase of ventilating pressure during anaesthesia (0.78%). Polygeline showed according to an improved preparation unexpected reactions only of the cutaneous anaphylactoid type (no severe systemic life threatening reaction, histamine liberation 1 ng/ml or less according to Lorenz).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6650802

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

1.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Anaphylactoid reactions to intravenous solutions used for volume substitution.

Authors:  J Ring
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

3.  In vitro colloid osmotic pressure of commonly used plasma expanders and substitutes: a study of the diffusibility of colloid molecules.

Authors:  A R Webb; S A Barclay; E D Bennett
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 4.  The use of plasma substitutes with special attention to their side effects.

Authors:  K F Messmer
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 5.  Choice of fluids for resuscitation in children with severe infection and shock: systematic review.

Authors:  Samuel Akech; Hannah Ledermann; Kathryn Maitland
Journal:  BMJ       Date:  2010-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.